Literature DB >> 7586362

Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.

K Lemström1, P Koskinen, L Krogerus, M Daemen, C Bruggeman, P Häyry.   

Abstract

BACKGROUND: Cardiac allograft arteriosclerosis is the primary cause of late death in heart transplant recipients. Clinical studies have suggested that humoral and cellular immune response, hyperlipidemia, and cytomegalovirus (CMV) infection may amplify the disease. In this study, the role of CMV infection in the development of rat cardiac allograft arteriosclerosis is investigated. METHODS AND
RESULTS: Heterotopic rat cardiac allografts were performed from the DA to the WF rat strains. To prevent rejection, the recipients received triple-drug (cyclosporine A 20 mg.kg-1.d-1, azathioprine 2 mg.kg-1.d-1, and methylprednisolone 0.5 mg.kg-1.d-1) immunosuppression postoperatively. Recipient rats were infected intraperitoneally (n = 21) with 10(5) plaque-forming units of rat CMV (RCMV) 1 day after transplantation or were left uninfected and used as controls (n = 18). The grafts were removed 7 and 14 days and 1 and 3 months after transplantation. In 42% (9 of 21) of cardiac allografts in RCMV-infected rats, an intramural, mononuclear cell inflammation of small intramyocardial arterioles was observed compared with none in uninfected rats (P = .005). Acute RCMV infection was associated with an early perivascular inflammatory cell response of helper T (W3/25), cytotoxic T (OX8), and NK (3.2.3) cells, macrophages (OX42), and major histocompatibility complex class II expression around small intramyocardial arterioles and capillaries. No upregulation of interleukin-2 receptor expression was seen. In arteries and small intramyocardial arterioles, RCMV infection was associated with a significant endothelial cell proliferation and a clear increase in intimal thickening. Significant endothelial cell proliferation was also observed in the capillaries after RCMV infection. Immunohistochemistry revealed specific focal RCMV early and late antigen expression in epicardial and interstitial ED1-immunoreactive mononuclear cell infiltrates and around small arterioles of RCMV-infected cardiac allografts. Occasionally, media cells of stenosed small intramyocardial arterioles also showed strong focal RCMV antigen expression. In addition, infectious RCMV could be recovered by plaque assay in cardiac allografts expressing RCMV antigens.
CONCLUSIONS: These results demonstrate a productive RCMV infection in cardiac allograft structures and suggest that RCMV infection accelerates cardiac allograft arteriosclerosis, particularly in small intramyocardial arterioles mediated by inflammatory responses in the vascular wall and perivascular space.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586362     DOI: 10.1161/01.cir.92.9.2594

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  Blood       Date:  2007-05-22       Impact factor: 22.113

3.  IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin.

Authors:  Sara Botto; Daniel N Streblow; Victor DeFilippis; Laura White; Craig N Kreklywich; Patricia P Smith; Patrizia Caposio
Journal:  Blood       Date:  2010-10-07       Impact factor: 22.113

4.  Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction.

Authors:  Cynthia A Bolovan-Fritts; Stephen A Spector
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

5.  Cytomegalovirus CC chemokine promotes immune cell migration.

Authors:  Jennifer Vomaske; Michael Denton; Craig Kreklywich; Takeshi Andoh; Jessica M Osborn; Daniel Chen; Ilhem Messaoudi; Susan L Orloff; Daniel N Streblow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

6.  Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  A Tiran; R A Tio; E Oostenveld; M C Harmsen; B Tiran; P Den Heijer; S H Monnink; M M Wilders-Truschnig; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

7.  Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.

Authors:  J A Graham; R A Wilkinson; T Hirohashi; C M Chase; R B Colvin; J C Madsen; J A Fishman; P S Russell
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

8.  Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing.

Authors:  Jerome Dumortier; Daniel N Streblow; Ashlee V Moses; Jon M Jacobs; Craig N Kreklywich; David Camp; Richard D Smith; Susan L Orloff; Jay A Nelson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

Review 9.  Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.

Authors:  D N Streblow; J Dumortier; A V Moses; S L Orloff; J A Nelson
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

10.  Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.

Authors:  C H Cook; A A Bickerstaff; J-J Wang; P D Zimmerman; M R Forster; T Nadasdy; R B Colvin; G A Hadley; C G Orosz
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.